Serrano-García B, Bartrina-Rodríguez I, Zubeldia-Varela JM, Cebrián-Carretero JL, del-Castillo-Pardo-de-Vera JL, Pardo-Montero J, et al. Preliminary study of the Craniofacial Pain and Disability Inventory-11: validation for patients with head and neck cancer. Med Oral Patol Oral Cir Bucal. 2021 Sep 1;26 (5):e661-8.
doi:10.4317/medoral. 24673
https://dx.doi.org/doi:10.4317/medoral.24673
1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695-709. |
PMid:18486742 |
2. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33:3235-42. |
PMid:26351338 PMCid:PMC4979086 |
3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-86. |
PMid:25220842 |
4. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301. |
PMid:21969503 PMCid:PMC3221528 |
5. Dios PD, Lestón JS. Oral cancer pain. Oral Oncol. 2010;46:448-51. |
PMid:20308009 |
6. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014;16:iv1-63. |
PMid:25304271 PMCid:PMC4193675 |
7. Gorsky M, Epstein JB, Oakley C, Le ND, Hay J, Stevenson-Moore P. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:546-52. |
PMid:15529126 |
8. Epstein J, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: part II-clinical perspectives and management. J Dent Res. 2007;86:506-18. |
PMid:17525349 |
9. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7:300-22. |
PMid:23475398 |
10. Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother. 2009;9:745-58. |
PMid:19402782 PMCid:PMC2696024 |
11. Madrid A, Carlos RJ, La Touche R, de Estudios CS, La Salle U, la Salle C. Craniofacial pain and disability inventory (CF-PDI): development and psychometric validation of a new questionnaire. Pain Physician. 2014;17:95-108. |
PMid:24452650 |
12. Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011;152:2399-404. |
PMid:21856077 |
13. La Touche R, Pardo-Montero J, Cuenca-Martínez F, Visscher CM, Paris-Alemany A, López-de-Uralde-Villanueva I. Cross-Cultural Adaptation and Psychometric Properties of the Spanish Version of the Tampa Scale for Kinesiophobia for Temporomandibular Disorders. J Clin Med. 2020;9:2831. |
PMid:32882930 PMCid:PMC7563282 |
14. García Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S. Validación de la versión española de la escala de la catastrofización ante el dolor (Pain Catastrophizing Scale) en la fibromialgia. Med Clin (Barc). 2008;131:487-92. |
PMid:19007576 |
15. López-Jornet P, Camacho-Alonso F, López-Tortosa J, Tovar TP, Rodríguez-Gonzales MA. Assessing quality of life in patients with head and neck cancer in Spain by means of EORTC QLQ-C30 and QLQ-H&N35. J Craniomaxillofac Surg. 2012;40:614-20. |
PMid:22425499 |
16. Rolke R, Baron R, Maier Ca, Tölle T, Treede R, Beyer A, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123:231-43. |
PMid:16697110 |
17. La Touche R, Paris-Alemany A, Gil-Martínez A, Pardo-Montero J, Angulo-Díaz-Parreño S, Fernández-Carnero J. Masticatory sensory-motor changes after an experimental chewing test influenced by pain catastrophizing and neck-pain-related disability in patients with headache attributed to temporomandibular disorders. J Headache Pain. 2015;16:20. |
PMid:25902781 PMCid:PMC4385233 |
18. Beltran-Alacreu H, López-de-Uralde-Villanueva I, Paris-Alemany A, Angulo-Díaz-Parreño S, La Touche R. Intra-rater and Inter-rater reliability of mandibular range of motion measures considering a neutral craniocervical position. J Phys Ther Sci. 2014;26:915-20. |
PMid:25013296 PMCid:PMC4085221 |
19. Lowery AE, Greenberg MA, Foster SL, Clark K, Casden DR, Loscalzo M, et al. Validation of a needs‐based biopsychosocial distress instrument for cancer patients. Psychooncology. 2012;21:1099-106. |
PMid:21830256 |
20. Shimizu K, Nakaya N, Saito-Nakaya K, Akechi T, Yamada Y, Fujimori M, et al. Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project. Ann Oncol. 2012;23:1973-9. |
PMid:22473594 |
21. Bilal S, Doss JG, Cella D, Rogers SN. Quality of life associated factors in head and neck cancer patients in a developing country using the FACT-H&N. J Craniomaxillofac Surg. 2015;43:274-80. |
PMid:25555894 |
22. Tesic M, Cankovic M, Jevtic M, Stevanovic D. Validation of the oral health impact profile - 14 in patients with head and neck cancer. Med Oral Patol Oral Cir Bucal. 2020;25:e739-44. |
PMid:32388514 PMCid:PMC7648921 |
23. Pace‐Balzan A, Cawood J, Howell R, Lowe D, Rogers S. The liverpool oral rehabilitation questionnaire: a pilot study. J Oral Rehabil. 2004;31:609-17. |
PMid:15189321 |
24. Rogers S, Forgie S, Lowe D, Precious L, Haran S, Tschiesner U. Development of the International Classification of Functioning, Disability and Health as a brief head and neck cancer patient questionnaire. Int J Oral Maxillofac Surg. 2010;39:975-82. |
PMid:20692122 |
25. Nazar G, Garmendia ML, Royer M, McDowell JA, Weymuller Jr EA, Yueh B. Spanish validation of the University of Washington Quality of Life questionnaire for head and neck cancer patients. Otolaryngol Head Neck Surg. 2010;143:801-7. |
PMid:21109081 |
26. Balaguer M, Percodani J, Woisard V. The Carcinologic Handicap Index (CHI): A disability self-assessment questionnaire for head and neck cancer patients. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:399-403. |
PMid:28826665 |
27. Rogers SN, Lowe D. An evaluation of the head and neck cancer patient concerns inventory across the Merseyside and Cheshire network. Br J Oral Maxillofac Surg. 2014;52:615-23. |
PMid:24927654 |
28. Simard EP, Torre LA, Jemal A. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol. 2014;50:387-403. |
PMid:24530208 |
29. Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ. Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer. 2010;18:801-10. |
PMid:19685346 PMCid:PMC3682075 |
30. Rogers SN, Cross B, Talwar C, Lowe D, Humphris G. A single-item screening question for fear of recurrence in head and neck cancer. Eur Arch Otorhinolaryngol. 2016;273:1235-42. |
PMid:25749490 |